May 16, 2026
RA Jainee
Baroda BNP Paribas Health and Wellness Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 10.07 |
| NAV Bonus (Rs.) | — |
| NAV IDCW (Rs.) | 10.07 |
| Min. Investment (Rs.) | 1,000 |
| Min. SIP Investment (Rs.) | 500 |
| Min. No of Cheques | 6 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 530 Cr |
| (As on 30-Apr-2026) | |
| Expense | 0.73% |
| 1 Year Return (%) | — |
| 3 Year Return (%) | — |
| 5 Year Return (%) | — |
| 10 Year Return (%) | — |
| Return Since Launch | 0.72% |
⚖️ Sahifund Review – Baroda BNP Paribas Health and Wellness Fund ✔
PLUS:
✓ Backed by the research capabilities and institutional credibility of Baroda BNP Paribas Mutual Fund in the thematic healthcare space.
✓ Expense ratio of 0.73% is relatively attractive compared to several established pharma and healthcare peers.
✓ Portfolio allocation across pharma, diagnostics, hospitals and healthcare services offers broader sector diversification.
✓ Mid-cap and small-cap exposure can generate strong alpha if the healthcare cycle remains favourable over the long term.
✓ Healthcare remains a structurally strong sector supported by rising healthcare spending, diagnostics demand and ageing demographics.
✓ Suitable mainly for aggressive SIP investors seeking tactical healthcare exposure alongside diversified equity funds.
✓ Fund size of Rs. 530 Cr is manageable and still flexible enough for portfolio adjustments without major liquidity constraints.
MINUS:
⚖️ Fund is extremely new with less than 1 year track record, making long-term performance evaluation difficult.
⚖️ Return since launch of just 0.72% significantly trails leading healthcare funds in the category.
⚖️ Recent momentum remains weak, with underperformance against both benchmark and sector average across shorter periods.
⚖️ Portfolio P/E of 44.32 indicates expensive valuations within the healthcare sector.
⚖️ High turnover ratio of 57% suggests elevated portfolio churn and active strategy risk.
⚖️ Sector concentration remains very high, with top 3 sectors accounting for over 97% exposure.
⚖️ Pharma and healthcare funds can witness prolonged underperformance when market preference shifts toward cyclicals or infrastructure themes.
Sahifund View (Decisive Line):
Baroda BNP Paribas Health and Wellness Fund is suitable only as a small satellite SIP allocation for high-risk investors, while diversified flexi-cap funds remain the safer long-term wealth creation option for most investors.
👉 Apply Online | Ask Us MF Queries |
| NFO Guidance |
What lies ahead? Below we decode returns consistency, portfolio concentration, peer positioning and risk profile in detail.
Suitable For Which Investors?
Nobody should invest in Pharma funds in our opinion, because:
• They have a narrow focus on only pharmaceutical and healthcare companies
• Instead, diversified equity funds which invest across sectors are better
If you still choose to invest:
1. Invest only through SIP
2. Have a 7+ year investment horizon
3. Be prepared to withstand interim sharp declines in investment value
Fund’s Investment Strategy:
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
Fund Manager:
1) Rohan Korde
Education: Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce
Experience: Prior to joining Baroda BNP Paribas Mutual Fund, he has worked with ITI Mutual Fund, BOB Capital Markets as Vice President
2) Sanjay Chawla
Education: Mr. Sanjay Chawla holds a Masters degree in Management Studies from BITS Pilani.
Experience: Prior to joining Baroda BNP Paribas Mutual Fund, he worked as Senior Fund Manager with BSL AMC. Before joining Birla, he worked as Head of Research with SBI Capital Markets and has worked in various capacities in equity research space in Motilal Oswal Securities, IDBI Capital Markets, SMIFS Securities, IIT Invest Trust & Lloyds Securities.
Investment Details
| Min. Investment (Rs) | 1,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 500 |
| Min. Withdrawal (Rs) | 1,000 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year |
Basic Details of Baroda BNP Paribas Health and Wellness Fund
| Fund House | Baroda BNP Paribas Mutual Fund |
| Launch Date | 27-Jun-25 |
| Return Since Launch | 0.72% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 530 Cr |
| (As on 30-Apr-2026) | |
| Expense | 0.73% |
| (As on 30-Apr-2026) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 57.00% |
Baroda BNP Paribas Health and Wellness Fund Returns
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Baroda BNP Paribas Health and Wellness Dir | 5.47 | 1.64 | 7.55 | 6.73 | 3.50 | — | — | — | — | — |
| BSE Healthcare TRI | 7.73 | 2.08 | 10.83 | 10.56 | 5.68 | — | — | — | — | — |
| Equity: Sectoral-Pharma | 8.13 | 1.75 | 10.12 | 10.38 | 6.10 | — | — | — | — | — |
| Rank within category | 20 | 16 | 23 | 23 | 20 | — | — | — | — | — |
| Number of funds in category | 24 | 25 | 25 | 24 | 23 | 21 | 12 | 10 | 8 | 4 |
Peer Comparison of Baroda BNP Paribas Health and Wellness Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| Baroda BNP Paribas Health and Wellness Dir | Unrated | — | — | — | 0.73 | 530 | 0.72 | 1.00 (365) | 10M | 57.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 5 out of 5 stars | 11.79 | 29.48 | 17.39 | 1.62 | 6,669 | 21.25 | 1.00 (15) | 7Y 10M | 57.00 |
| SBI Healthcare Opportunities Dir | 5 out of 5 stars | 12.38 | 27.80 | 17.20 | 0.92 | 4,323 | 17.73 | 0.50 (15) | 13Y 4M | 25.00 |
| UTI Healthcare Dir | 4 out of 5 stars | 14.34 | 28.28 | 15.55 | 1.36 | 1,144 | 16.05 | 1.00 (30) | 13Y 4M | 33.00 |
| Nippon India Pharma Dir | 3 out of 5 stars | 10.90 | 25.08 | 14.67 | 1.48 | 8,365 | 17.58 | 1.00 (30) | 13Y 4M | 14.00 |
Baroda BNP Paribas Health and Wellness Fund Portfolio
| No. of Stocks | 35 |
| Top 10 Stocks | 52.94% |
| Top 5 Stocks | 31.22% |
| Top 3 Sectors | 97.26% |
| Portfolio P/B Ratio | 6.64 |
| Portfolio P/E Ratio | 44.32 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 60,219 | 77,752 |
| Giant (%) | — | — |
| Large (%) | 27.44 | 41.80 |
| Mid (%) | 37.33 | 31.80 |
| Small (%) | 35.23 | 28.94 |
| Tiny (%) | — | — |
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status